Towards a national pharmaceutical strategy in Lebanon: Ensuring access to quality and safe medications for all
DOI:
https://doi.org/10.46542/pe.2023.231.165179Keywords:
Access to medication, LMIC, Pharmaceutical strategy, Quality medication, StakeholderAbstract
Introduction: Lebanon is facing challenges affecting the whole health sector, including access to medications. Lebanon has only proposed very few short-term national pharmaceutical strategic solutions. Previous reform attempts targeting the pharmaceutical sector, could not protect it from the crises and their detrimental consequences on patient and population health.
Purpose: This document unveils the critical elements that should be addressed in the planned National Pharmaceutical Sector Strategy (NPS) being developed by the Order of Pharmacists of Lebanon (OPL) in consultation with the concerned stakeholders.
Method: Strategic goals were proposed for adoption and implementation by the competent authorities based on consultations, situational assessments, and gap analyses. The objectives and an implementation plan were developed based on the available resources and policy dialogue, respectively.
Conclusion: The National Pharmaceutical Strategy would help the Lebanese authorities/policy-makers, aided by competent healthcare professionals, develop and implement a time-bound roadmap to attain a nation with access to quality and safe medications for the whole population. Implementing this strategy would require the commitment of decision-makers, the accountability of involved parties, innovation in finding solutions, close collaboration between stakeholders, and lengthy efforts to attain the stated vision.
References
AbouAssi, K. (2015). The third wheel in public policy: an overview of NGOs in Lebanon. Public administration and policy in the Middle East, 215-230. https://media-ghi.ghi.aub.edu.lb/wp-content/uploads/2019/12/The-Third-Wheel-in-Public-Policy-An-Overview-of-NGOs-in-Lebanon.pdf
Akel, M., Hajj, A., Sacre, H., Zeenny, R.M., Haddad, C. & Salameh, P. (2022). Developing a national pharmaceutical research strategy in Lebanon: Opportunities to bridge the gaps and reach the goals. Journal of Pharmaceutical Policy and Practice, 15(1):83. https://doi.org/10.1186/s40545-022-00485-1
Ammar, M.A., Tran, L.J., McGill, B., Ammar, A.A., Huynh, P., Amin, N., Guerra, M., Rouse, G.E., Lemieux, D., McManus, D., Topal, J.E., Davis, M.W., Miller, L., Yazdi, M., Leber, M.B. & Pulk, R.A. (2021). Pharmacists leadership in a medication shortage response: Illustrative examples from a health system response to the COVID-19 crisis. Journal of the American College of Clinical Pharmacy, 4(9):1134–1143. https://doi.org/10.1002/jac5.1443
Balkhi, B., Alshayban, D. & Alotaibi, N.M. (2021). Impact of Healthcare Expenditures on Healthcare Outcomes in the Middle East and North Africa (MENA) Region: A Cross-Country Comparison, 1995-2015. Frontiers in public health, 8:624962. https://doi.org/10.3389/fpubh.2020.6249622
Brown, M.T. & Bussell, J.K. (2011). Medication adherence: WHO cares?. Mayo Clinic Proceedings, 86(4):304–314. https://doi.org/10.4065/mcp.2010.0575
El-Harakeh, A. & Haley, S.J. (2022). Improving the availability of prescription drugs in Lebanon: a critical analysis of alternative policy options. Health research policy and systems, 20(1):106. https://doi.org/10.1186/s12961-022-00921-3
El-Jardali, F., Fadlallah, R., Morsi, R.Z., Hemadi, N., Al-Gibbawi, M., Haj, M., Khalil, S., Saklawi, Y., Jamal, D. & Akl, E.A. (2017). Pharmacists’ views and reported practices in relation to a new generic drug substitution policy in Lebanon: A mixed methods study. Implementation Science, 12(1):23. https://doi.org/10.1186/s13012-017-0556-1
ESCWA. (2021). Multidimensional poverty in Lebanon (2019-2021): Painful reality and uncertain prospects. https://www.unescwa.org/sites/default/files/pubs/pdf/multidimensional-poverty-lebanon-2019-2021-english.pdf
Fleifel, M. & Abi Farraj, K. (2022). The Lebanese Healthcare Crisis: An Infinite Calamity. Cureus, 14(5):e25367. https://doi.org/10.7759/cureus.25367
GBD 2015 Healthcare Access and Quality Collaborators. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the Global Burden of Disease Study 2015. Lancet (London, England), 390(10091):231–266. https://doi.org/10.1016/S0140-6736(17)30818-8
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Diseases Study 2016. Lancet, 390(10100):1211. https://doi.org/10.1016/S0140-6736(17)32154-2
Hajj, A., Azzo, C., Hallit, S., Salameh, P., Sacre, H., Abdou, F., Naaman, N. & Khabbaz, L.R. (2021). Assessment of drug-prescribing perception and practice among dental care providers: a cross-sectional Lebanese study. Pharmacy Practice, 19(1): 2234. https://doi.org/10.18549/PharmPract.2021.1.2234
Hajj, A., Sacre, H., Hallit, S., Zeenny, R. M., Sili, G. & Salameh, P. (2020). Prescription and dispensing guidelines in Lebanon: initiative of the Order of Pharmacists of Lebanon. Journal of pharmaceutical policy and practice, 13(1):70. https://doi.org/10.1186/s40545-020-00273-9
Hajj, A., Zeenny, R.M., Sacre, H., Akel, M., Haddad, C. & Salameh, P. (2023). Pharmacy education and workforce: strategic recommendations based on expert consensus in Lebanon. Journal of pharmaceutical policy and practice, 16(1):1. https://doi.org/10.1186/s40545-022-00510-3
Hamadeh, N., Van Rompaey, C., Metreau, E. & Eapen, S.G. (2022). New World Bank country classifications by income level: 2022-2023. https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2022-2023
IDAL. (2018). Pharmaceutical Sector in Lebanon. 2018 Factbook (p. 11). https://investinlebanon.gov.lb/Content/uploads/Publication/190409035043756~IDAL%20-%20Pharmaceutical%20Industry%20Fact%20Book%202018.pdf
Jebeli, S.S.H., Hadian, M. & Souresrafil, A. (2019). Study of health resource and health outcomes: Organization of economic corporation and development panel data analysis. Journal of education and health promotion, 8:70. https://www.jehp.net//text.asp?2019/8/1/70/256999
Khazzaka, M. (2019). Pharmaceutical marketing strategies’ influence on physicians’ prescribing pattern in Lebanon: Ethics, gifts, and samples. BMC Health Services Research, 19(1):80. https://doi.org/10.1186/s12913-019-3887-6
Lebanese Parliament (2002). Law 253 (May 1, 2022): Creation of the Lebanese Drug Agency. The Official Gazette, 2: 125-133. http://77.42.251.205/Law.aspx?lawid=289041
Leonardo Alves, T., Lexchin, J. & Mintzes, B. (2019). Medicines Information and the Regulation of the Promotion of Pharmaceuticals. Science and Engineering Ethics, 25(4):1167–1192. https://doi.org/10.1007/s11948-018-0041-5
Malik, K. (2013). Human Development Report 2013. The rise of the South: Human progress in a diverse world. United Nations Development Programme https://hdr.undp.org/system/files/documents/global-report-document/hdr2013encompletepdf.pdf
McKinsey & Company. (2018). Lebanon Economic Vision. The McKinsey Full Report 2018 (p. 1274). https://www.economy.gov.lb/media/11893/20181022-1228full-report-en.pdf
McKulka, T. (n.d.). The resilience of nations is manifest in their ability to anticipate and prepare for shocks, which, in turn, depends on the technical capacities of organisations and institutions at the front lines of crisis response, the overall functioning of country systems, and the governance structures that ‘set the rules of the game’. https://www.undp.org/sites/g/files/zskgke326/files/publications/Towards_SustainingMDGProgress_Ch8.pdf
Ministry of Public Health (2020). Decision related to the bases of drug pricing in Lebanon. https://www.moph.gov.lb/Laws/download_file/4674
Ministry of Public Health (nd). Lebanon Clinical Trial Registry (LBCTR). https://lbctr.moph.gov.lb
Ministry of Public Health Lebanon. (2019). Pharmacovigilance System in Lebanon https://www.moph.gov.lb/en/Pages/4/44742/pharmacovigilance-system-lebanon
Ministry of Public Health. (2014). Guidelines on Good Storage and Distribution Practices of Pharmaceutical Products in Lebanon (Third Edition) (p. 35). Ministry of Public Health. https://www.moph.gov.lb/userfiles/files/HealthCareSystem/Pharmaceuticals/QualityAssuranceofPharmaceuticalProducts/Guidelines-GSDPLebanon(English).pdf
Office of the United States Trade Representative. (2022). USTR Releases 2022 Special 301 Report on Intellectual Property Protection and Enforcement. United States Trade Representative. http://ustr.gov/about-us/policy-offices/press-office/press-releases/2022/april/ustr-releases-2022-special-301-report-intellectual-property-protection-and-enforcement
Panteli, D. & Edwards, S. (2018). Ensuring access to medicines: How to stimulate innovation to meet patients’ needs? (E. Richardson, W. Palm, & E. Mossialos, Eds.). European Observatory on Health Systems and Policies. http://www.ncbi.nlm.nih.gov/books/NBK526400/
Research Center for Drug Evaluation and Research. (2017). Drugs@FDA Glossary of Terms. FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms
Saleh, N., Awada, S., Awwad, R., Jibai, S., Arfoul, C., Zaiter, L., Dib, W. & Salameh, P. (2015). Evaluation of antibiotic prescription in the Lebanese community: a pilot study. Infection ecology & epidemiology, 5:27094. https://doi.org/10.3402/iee.v5.27094
Siddiqi, S., Masud, T.I., Nishtar, S., Peters, D.H., Sabri, B., Bile, K.M. & Jama, M.A. (2009). Framework for assessing governance of the health system in developing countries: Gateway to good governance. Health Policy (Amsterdam, Netherlands), 90(1):13–25. https://doi.org/10.1016/j.healthpol.2008.08.005
World Health Organisation Regional Office for the Eastern Mediterranean. (2020). Regional strategy to improve access to medicines and vaccines in the Eastern Mediterranean, 2020–2030, including lessons from the COVID-19 pandemic (EM/RC67/6). World Health Organisation Regional Office for the Eastern Mediterranean. https://apps.who.int/iris/handle/10665/335952
World Health Organisation. (2001). How to Develop and Implement a National Drug Policy—2nd ed. (p. 96). https://www.who.int/publications-detail-redirect/924154547X
Zeenny, R., Wakim, S. & Kuyumjian, Y.M. (2017). Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteria. Clinical interventions in ageing, 12:65–73. https://doi.org/10.2147/CIA.S87564
